A comparison of early effects with two dose rates in brachytherapy of cervix carcinoma in a prospective randomised trialLAMBIN, P; GERBAULET, A; KRAMAR, A et al.European journal of cancer. Part A. 1994, Vol 30, Num 3, pp 312-320Article

Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinomaHAIE-MEDER, C; KRAMAR, A; LAMBIN, P et al.International journal of radiation oncology, biology, physics. 1994, Vol 29, Num 5, pp 953-960, issn 0360-3016Conference Paper

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors : a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)CULINE, S; KERBRAT, P; BIRON, P et al.Annals of oncology. 2007, Vol 18, Num 5, pp 917-924, issn 0923-7534, 8 p.Article

Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours : preliminary results of a French randomized trial. DiscussionCHEVREAU, C; DROZ, J. P; BOUZY, J et al.CHEVREAU, C; European urology. 1993, Vol 23, Num 1, pp 213-218, issn 0302-2838Conference Paper

High-dose chemotherapy with ABMT in the first line treatment of poor risk non-seminomatous germ cell tumorsDROZ, J. P; PICO, J. L; BIRON, P et al.Bone marrow transplantation. Supplement (Basingstoke). 1992, Vol 10, Num 2, issn 0951-3078, p. 27Conference Paper

Tumour size in cancer of the cervixLAMBIN, P; KRAMAR, A; HAIE-MEDER, C et al.Acta oncologica (Stockholm). 1998, Vol 37, Num 7-8, pp 729-734, issn 0284-186XConference Paper

Basal cell carcinoma of the face : surgery or radiotherapy? Results of a randomized studyAVRIL, M.-F; AUPERIN, A; PRADE, M et al.British journal of cancer. 1997, Vol 76, Num 1, pp 100-106, issn 0007-0920Article

Méthode d'évaluation des complications tardives. Étude basée sur un essai de phase III comparant deux faible débits de dose en curiethérapie gynécologique = Method for evaluating long term complications. Study from a phase III trial comparing two low dose rates in gynaecological brachytherapyLANCAR, R; KRAMAR, A; HAIE-MEDER, C et al.Bulletin du cancer. 1994, Vol 81, Num 7, pp 632-637, issn 0007-4551Article

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trialGROSS-GOUPIL, M; FOURCADE, A; KAMINSKY, M. C et al.European journal of cancer (1990). 2012, Vol 48, Num 5, pp 721-727, issn 0959-8049, 7 p.Article

Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT) : results of the sCR2 international studyFIZAZI, K; OLDENBURG, J; TJULANDIN, S et al.Annals of oncology. 2008, Vol 19, Num 2, pp 259-264, issn 0923-7534, 6 p.Article

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursPICO, J.-L; ROSTI, G; MARANGOLO, M et al.Annals of oncology. 2005, Vol 16, Num 7, pp 1152-1159, issn 0923-7534, 8 p.Article

Prognostic factors in non-seminomatous germ cell tumours of the testis : experience at the Institut Gustave-Roussy. DiscussionKRAMAR, A; DROZ, J. P; REY, A et al.European urology. 1993, Vol 23, Num 1, pp 188-195, issn 0302-2838Conference Paper